Lozada, Reynaldo T.
HRN: 11-63-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2025
MUPIROCIN 2%, 15G (TUBE)
11/26/2025
12/02/2025
TOPICAL
Apply
Bid
Decubitus Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes